Home › Crohn's Disease › Pennsylvania › Philadelphia
Crohn's Disease clinical trials in Philadelphia, PA
13 studies for Crohn's Disease are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
RecruitingPhase 3
- Thomas Jefferson University Hospital ( Site 5133), Philadelphia
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
RecruitingPhase 2
- University of Pennsylvania - Perelman Center for Advanced Medicine /ID# 265904, Philadelphia
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
RecruitingPhase 3
- Children's Hospital of Philadelphia, Philadelphia
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
RecruitingPhase 2/3
- University of Pennsylvania, Philadelphia
- Jefferson Digestive Health Institute, Philadelphia
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
RecruitingPhase 3
- Thomas Jefferson University - Medicine/GI and Hepatology, Philadelphia
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
RecruitingPhase 3
- University of Pennsylvania School of Medicine-Site Number: 8400072, Philadelphia
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
RecruitingPhase 3
- University of Pennsylvania School of Medicine-Site Number: 8400072, Philadelphia
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
RecruitingPhase 3
- Children's Hospital of Philadelphia (CHOP), Philadelphia
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
RecruitingPhase 3
- Children's Hospital of Philadelphia, Philadelphia
Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
RecruitingPhase 3
- Children's Hospital of Philadelphia - Main /ID# 262197, Philadelphia
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
RecruitingPhase 4
- Children's Hospital of Philadelphia, Philadelphia
Precise Infliximab Exposure and Pharmacodynamic Control
RecruitingPhase 2/3
- Nemours Children's Health System-Wilmington, Wilmington · 25 mi away
Reverse-Engineering of Exclusive Enteral Nutrition (RE-EEN) in Crohn's Disease: A Multi-Center Trial
Recruiting
- Children's Hospital of Philadelphia, Philadelphia
About Crohn's Disease
Crohn's Disease can cause inflammation in any area from the mouth to the anus. Read about medicines, surgery or dietary management to treat symptoms.
More about Crohn's Disease on MedlinePlus
Crohn's Disease trials in other cities
- New York City, NY35 studies
- Boston, MA19 studies
- Miami, FL19 studies
- Cleveland, OH19 studies
- St. Louis, MO19 studies
- Tyler, TX17 studies
- Houston, TX17 studies
- Orlando, FL17 studies
- Atlanta, GA17 studies
- San Antonio, TX15 studies
- Los Angeles, CA15 studies
- San Diego, CA15 studies
Other studies in Philadelphia
- Cancer (all types)59 studies
- Breast Cancer56 studies
- Non-Small Cell Lung Cancer51 studies
- Metastatic Cancer46 studies
- Prostate Cancer44 studies
- Colorectal Cancer44 studies
- Ovarian Cancer44 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Heart Failure31 studies
- Endometrial Cancer28 studies
- Depression26 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.